Kanaph Therapeutics카나프테라퓨틱스
0082N0 · KOSDAQ · ₩0082N0 · 카나프테라퓨틱스
₩10,030▲ ₩220 (2.24%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | |
|---|---|
| Revenue | ₩5.6B |
| Operating income | −₩4.3B |
| Net income | −₩36B |
| Net income to shareholders | −₩36B |
Balance sheet
| 2025 | |
|---|---|
| Total assets | ₩15B |
| Current assets | ₩14B |
| Cash and equivalents | ₩1.2B |
| Total liabilities | ₩3.1B |
| Current liabilities | ₩2.4B |
| Total equity | ₩12B |
| Shareholders' equity | ₩12B |
Cash flow
| 2025 | |
|---|---|
| Cash from operations | −₩7.2B |
| Capital spending | ₩77M |
| Free cash flow | −₩7.2B |
Consolidated where available. Amounts in won.
Also known as: Kanaph Therapeutics / 카나프테라퓨틱스 / 0082N0 / KRX:0082N0
Source: KRX statistical information